Search for: "K-V Pharmaceutical Company" Results 161 - 180 of 221
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 May 2011, 4:59 am by Marie Louise
(Kluwer Patent Blog) USPTO statement at WIPO side event on Medicines Patent Pool (Knowledge Ecology International) US: To implement health reform orphan drug exclusion, HRSA issues first-ever proposed regulation on 340B drug discount program (FDA Law Blog) US: FDA officials hint at provisions of biosimilar guidances (Patent Docs) US: Huffington Post: Data Exclusivity: Getting the balance right (PatentlyBIOtech) US: Report gauges economic impact of Human Genome Project (Patent Docs) US: Chairman… [read post]
20 May 2011, 11:15 pm by Apeng
Leave granted to appeal to Supreme Court of Canada on K-12 decision – CMEC v. [read post]
1 Feb 2011, 4:01 am by Maxwell Kennerly
There's been a wave of antitrust class actions predicated on patent misuse by pharmaceutical companies of the past decade. [read post]
25 Jan 2011, 10:58 pm by Marie Louise
General GSK critiques Anti-Counterfeiting Trade Agreement (IP Watch) WHO Members show dismay at delay on Counterfeit Medicines Group (IP Watch) WHO R&D financing committee approved with controversial industry expert (IP Watch) (KEI) (KEI) (KEI) BioCentury this week explores orphan drugs with HP&M attorney and NORD Board Chair (FDA Law Blog) EU: Paediatric extensions and transitional provisions: a question of timing (The SPC Blog) India: Patent Office continue refusing pharmaceutical… [read post]
3 Jan 2011, 9:45 pm by Law Lady
Pharmaceuticals: GLAXO AND SUBSIDIARY SETTLE CIVIL, CRIMINAL CASES FOR $750 MILLION, United States v. [read post]
19 Oct 2010, 10:42 pm by Marie Louise
  Highlights this week included: CAFC denies outsourcing of inventorship to foreign countries: Solvay v. [read post]